The anti-MRSA compound 3-O-alpha-L-(2?,3?-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus.

The anti-MRSA compound 3-O-alpha-L-(2?,3?-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus. J Proteomics. 2020 01 06; 210:103539.

View in: PubMed

subject areas

Anti-Bacterial Agents
Bacterial Proteins
Humans
Kaempferols
Methicillin-Resistant Staphylococcus aureus
Microbial Sensitivity Tests
Protein Biosynthesis
Protein Synthesis Inhibitors
Proteomics
Rhamnose
Staphylococcal Infections

authors with profiles

Mark T. Hamann